期刊文献+

3.0T磁共振动态对比增强扫描在脑胶质瘤分级诊断中的应用 被引量:35

Application of 3.0T Dynamic Contrast-enhanced MRI in the Grading of Gliomas
下载PDF
导出
摘要 目的探讨3.0T磁共振动态对比增强扫描(DCE-MRI)对术前颅内胶质瘤病理分级的诊断价值。方法对40例经手术病理证实的脑肿瘤患者(其中脑胶质瘤患者29例)均行常规磁共振(MRI)及DCE-MRI检查,利用GE MR工作站的Kinetic Modeling-version 3.0软件计算颅内肿瘤实质区相应的动态灌注扫描定量参数Ktrans和Ve值,比较任意2个分级之间各定量参数差异,分析颅内不同级别胶质瘤动态增强扫描参数的特点,并利用受试者工作特性曲线(ROC)对Ktrans值及Ve值进行分析。结果应用DCE-MRI获得的定量参数ktrans值、Ve值在Ⅲ级与Ⅳ级的高级别胶质瘤均明显高于Ⅰ级与Ⅱ级的低级别胶质瘤(P<0.05);Ⅰ级与Ⅱ级,Ⅲ级与Ⅳ级胶质瘤之间Ktrans值、Ve值无统计学差异(P>0.05)。鉴别低级别胶质瘤与高级别胶质瘤Ktrans诊断阈值为0.204/min,Ve诊断阈值为0.099。区分Ⅱ级胶质瘤与Ⅲ级胶质瘤Ktrans诊断阈值为0.247/min,Ve诊断阈值为0.176。结论结合3.0T DCE-MRI的定量参数Ktrans值、Ve值及常规MRI增强扫描可以在术前区分低级别与高级别胶质瘤,也可用于区别Ⅱ级与Ⅲ级胶质瘤,而低级别胶质瘤中的Ⅰ级与Ⅱ级、高级别胶质瘤中的Ⅲ级与Ⅳ级无法鉴别,对于术前无创性评价肿瘤病理分级具有临床指导价值。 Objective To explore the clinical significance of 3.0T dynamic-contrast enhanced MRI scan in the grading of intracranial glioma.Methods The magnetic resonance examination were performed in 40 cases of patients of brain tumors confirmed by surgery pathology(29 patients with glioma),including conventional MRI and dynamic contrast-enhanced MRI. Using Kinetic Modeling-version 3.0 software on the GE 3.0T magnetic resonance workstation calculation of intracranial tumor parenchyma area corresponding quantitative parameters Ktrans and Ve values.The quantitative parameters between any two classification were compared,and the difference was statistically analyzed. The characteristics of the different level of intracranial glioma's dynamic enhanced scan parameters were preliminary analyzed. The receiver-operating characteristic curve(ROC)analysis of Ktrans value and Ve value was performed,and the diagnosed threshold,sensitivity and specificity were acquired. Results While applying dynamic-contrast enhanced MRI scan acquired Ktrans and Ve values,both values of high grade gliomas include gradeⅢand Ⅳwere significantly higher than that of low grade gliomas include gradeⅠandⅡ(P〈0.05);there was no statistically difference of the parameters of Ktrans and Ve values between gradesⅠwithⅡand gradeⅢwith Ⅳ(P〉0.05). To identify low grade gliomas with high grade glioma,Ktrans and Ve diagnosis threshold was 0.204 /min and 0.099 respectively. To distinguish between gradeⅡ and Ⅲ glioma,Ktrans and Ve diagnosis threshold was 0.247 /min and 0.176 respectively. Conclusion Combining quantitative parameters Ktrans and Ve value that come from 3.0T dynamic contrast enhanced MRI scan with regular enhancement MRI can distinguish low grade gliomas with high grade gliomas glioma,as well as distinguish grade Ⅱ with Ⅲ glioma;However,it is still difficult to identify low grade gliomaⅠwithⅡ,as well as high grade glioma Ⅲ with Ⅳ. The Ktrans and Ve value plays an important role in discriminate different grade intracranial tumors in a preoperative noninvasive way.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2016年第7期620-625,共6页 Journal of China Medical University
关键词 动态对比增强磁共振 脑胶质瘤 分级 诊断 容积转运常数 dynamic contrast-enhanced magnetic resonance imaging brain gliomas grade diagnosis volume transfer constant
  • 相关文献

参考文献20

  • 1OIKE T, SUZUKI Y, SUGAWARA K, et al. Radiotherapy plus con- comitant adjuvant temozolomide for glioblastoma:Japanese mono-in- stitutional results [ J ]. Plos One, 2013,8 ( 11 ) : e78943-e78943.
  • 2WANG S, CHEN Y, LAI B, et al. Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imag- ing [ J 1. J Neurooneol, 2012,107 ( 1 ) : 51-60.
  • 3TOYOOKA M, KIMUtlA H, UEMATSU H, et al.Tissue eharaeteriza- tion of glioma by proton magnetic resonance spectroscopy and peffu-sion-weighted magneticresonance imaging : glioma grading and histo- logical correlation [ J 1. Clin Imaging, 2008,32 ( 4 ) : 251-258.
  • 4王效春,张辉,秦江波,王乐,吴晓峰.磁敏感加权成像与动态磁敏感加权对比增强MR灌注加权成像联合应用在脑星形细胞瘤分级中的价值[J].中华放射学杂志,2012,46(11):988-992. 被引量:9
  • 5SIBEL K, AYSEGUL C, ETEM A, et al. Contribution of diffusion- weighted imaging to dynamic contrast-enhanced MRI in the charac- terization of breast tumors [J]. Am J Roentgenol, 2011,196 (1) : 210-217.
  • 6NG CS, RAUNIG DL,JACKSON EF, et al. Reproducibility of perfu- siou parameters in dynamic contrast-enhanced MRI of lung and liv- er tumors : effect on estimates of patient sample size in clinical trials and on individual patient responses [J]. Am J Roentgenol, 2010, 194(2) :W134-W140.
  • 7HARIS M, HUSAIN N, SINGH A, et al. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with nocorreetion for vascular endothelial gTowth factor, micro- vascular density, and grading of astrocytoma [J]. J Comput Assist Tomogr, 2008,32(6) : 955-965.
  • 8ARGYRIOU AA, GIANNOPOULOU E, KALOFONOS HP. Angio- genesis and anti-angiogenic molecularly targeted therapies in malig- nant gli [J]. Ontology,2009,77 ( 1 ): 1-11.
  • 9ALMEIDA-FREITAS DB, PINHO MC, OTADUY MC, et al. Assess- ment of irradiated brain metastases using dynamic contrast - en- hanced magnetic resonance imaging [J]. Neuroradiology, 2014, 56 (6) :437-443.
  • 10HARIS M, GUPTA RK, SINGH A, et al. Differentiation of infective from neoplastic brain Lesions by dynamic contrast-enhanced MRI [J]. Neuroradiology, 2008,50(6) :531-540.

二级参考文献66

  • 1Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR, 2004, 25:746-755.
  • 2Law M, Young R, Babb J, et al. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR, 2007, 28:761-766.
  • 3Lupo JM, Cha S, Chang SM, et al. Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. AJNR, 2007, 28:1455-1461.
  • 4Hilario A, Ramos A, Perez-Nunez A, et al. The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. AJNR, 2012, 33: 701-707.
  • 5Park M J, Kim HS, Jahng GH, et al. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR, 2009, 30 : 1402-1408.
  • 6Kim HS, Jahng GH, Ryu CW, et al. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR, 2009, 30:1574-1579.
  • 7Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 2007,114:97-109.
  • 8Brasil CG, Ciccarelli O, Altmann DR, et al. Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology, 2009, 253 : 505-512.
  • 9Sawlani RN, Raizer J, Horowitz SW, et al. Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging pilot study. Radiology, 2010, 255:622-625.
  • 10Park SM, Kim HS, Jahng GH, et al. Combination of high- resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T. Br J Radiol, 2010, 83:466-475.

共引文献54

同被引文献245

引证文献35

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部